Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

[Predictors of reversion to sinus rhythm previous to electrical cardioversion in patients with persistent atrial fibrillation treated with anti-arrhythmic drugs].

Viñolas X, Freire F, Romero-Menor C, Alegret JM.

Med Clin (Barc). 2013 Apr 20;140(8):351-5. doi: 10.1016/j.medcli.2012.02.026. Epub 2012 Sep 14. Spanish.

PMID:
22982132
2.

Atrial fibrillation: rate control often better than rhythm control.

[No authors listed]

Prescrire Int. 2004 Apr;13(70):64-9.

PMID:
15148984
3.

Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.

Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J.

Am J Cardiol. 2003 Mar 20;91(6A):15D-26D. Review.

PMID:
12670638
4.

[Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].

Márk L, Erdej F, Dani G, Borbély M, Sziklai G, Nagy E, Hajdara I, Katona A.

Orv Hetil. 2004 May 9;145(19):1001-6. Hungarian.

PMID:
15181735
6.

Pharmacologic reversion of persistent atrial fibrillation with amiodarone predicts long-term sinus rhythm maintenance.

Galperín J, Elizari MV, Chiale PA, Molina RT, Ledesma R, Scapín AO, Blanco MV, Bonato R, Lago M; Grupo de Estudio de Fibrilación Auricular Con Amiodarona (GEFACA) Investigators..

J Cardiovasc Pharmacol Ther. 2003 Sep;8(3):179-86.

PMID:
14506542
8.

Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters.

Biffi M, Boriani G, Bartolotti M, Bacchi Reggiani L, Zannoli R, Branzi A.

Heart. 2002 May;87(5):443-8.

9.
10.

[Effect of diabetes mellitus in recovery and maintenance of sinus rhythm in patients with persistent atrial fibrillation].

Potpara T, Marinković-Erić J, Grujić M, Radojković-Cirović B, Vujisić-Tesić B, Petrović M.

Srp Arh Celok Lek. 2002 May-Jun;130(5-6):189-92. Serbian.

11.

Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.

Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagné P, Nattel S, Thibault B.

N Engl J Med. 2000 Mar 30;342(13):913-20.

12.

Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation.

Tuinenburg AE, Van Gelder IC, Van Den Berg MP, Brügemann J, De Kam PJ, Crijns HJ.

Heart. 1999 Oct;82(4):486-93.

13.

Activation of the hemostatic mechanism after pharmacological cardioversion of acute nonvalvular atrial fibrillation.

Oltrona L, Broccolino M, Merlini PA, Spinola A, Pezzano A, Mannucci PM.

Circulation. 1997 Apr 15;95(8):2003-6.

14.

Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.

Singh SN, Tang XC, Reda D, Singh BN.

Heart Rhythm. 2009 Feb;6(2):152-5. doi: 10.1016/j.hrthm.2008.10.036. Epub 2008 Oct 29.

PMID:
19187902
15.
16.

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.

Gillis AM, Verma A, Talajic M, Nattel S, Dorian P; CCS Atrial Fibrillation Guidelines Committee..

Can J Cardiol. 2011 Jan-Feb;27(1):47-59. doi: 10.1016/j.cjca.2010.11.001. Erratum in: Can J Cardiol. 2011 May-Jun;27(3):388.

PMID:
21329862
17.

A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.

Vijayalakshmi K, Whittaker VJ, Sutton A, Campbell P, Wright RA, Hall JA, Harcombe AA, Linker NJ, Stewart MJ, Davies A, de Belder MA.

Am Heart J. 2006 Apr;151(4):863.e1-6.

PMID:
16569550
18.

Arrhythmias in the intensive care patient.

Trappe HJ, Brandts B, Weismueller P.

Curr Opin Crit Care. 2003 Oct;9(5):345-55. Review.

PMID:
14508146
19.

Factors influencing long term persistence of sinus rhythm after a first electrical cardioversion for atrial fibrillation.

Duytschaever M, Haerynck F, Tavernier R, Jordaens L.

Pacing Clin Electrophysiol. 1998 Jan;21(1 Pt 2):284-7.

PMID:
9474689
20.

Rate-control versus conversion strategy in postoperative atrial fibrillation: trial design and pilot study results.

Lee JK, Klein GJ, Krahn AD, Yee R, Zarnke K, Simpson C, Skanes A.

Card Electrophysiol Rev. 2003 Jun;7(2):178-84.

PMID:
14618047

Supplemental Content

Support Center